Cocoon Biotech
Peter Mitchell has been with Cocoon Biotech for over 4 years. In total he has over 30 years experience in pharmaceuticals and biotechnology, including 25 years with Pfizer and Eli Lilly. Peter has both a BSc. honors degree in biochemistry and a Ph.D. in analytical chemistry and in addition has authored more than 50 peer-reviewed publications. During his R&D career he has worked across scientific disciplines including analytical chemistry, cell biology, molecular biology and biochemistry. Peter has extensive pharmaceutical R&D experience both as a scientific leader and in senior management.
This person is not in any offices
Cocoon Biotech
Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori).